癌症研究
化学
钙网蛋白
免疫原性细胞死亡
基因敲除
谷胱甘肽
细胞外
细胞生长
免疫系统
自噬
活性氧
GCLC公司
细胞
GPX4
细胞内
细胞培养
顺铂
平衡
程序性细胞死亡
生物
CD8型
信号转导
癌细胞
细胞生物学
细胞毒性
丁硫胺
作者
Ting Zhu,Bin Wang,Haiyong Wang,Jianyi Ding,Yangjun Xu,Jianfeng Xu,Lingjun Dong,Xiang Wang,Guangmao Yu,Zhupeng Li
标识
DOI:10.3389/fimmu.2026.1967436
摘要
Cisplatin resistance remains a major therapeutic challenge in esophageal squamous cell carcinoma (ESCC). Here, we investigated the antitumor effects and underlying mechanisms of Huayu Wan (HYW) in cisplatin-resistant ESCC. HYW markedly inhibited the growth of cisplatin-resistant human KYSE150 and murine mEC25 cells and induced a ferroptotic phenotype characterized by reactive oxygen species accumulation, increased intracellular iron, glutathione depletion, lipid peroxidation, and reduced GPX4 expression. Ferrostatin-1 partially reversed HYW-induced cytotoxicity. HYW also promoted immunogenic cell death-associated changes, including extracellular ATP and HMGB1 release and cell-surface calreticulin exposure. Mechanistically, HYW increased p53 expression and impaired the SLC7A11/GCLC-dependent cystine–glutathione antioxidant system, whereas GCLC overexpression and P53 inhibition partially restored redox homeostasis and cell survival. In parallel, HYW suppressed AKT–mTOR signaling and promoted NCOA4-associated ferritinophagy, as evidenced by increased NCOA4 and LC3-II and decreased FTH expression. Pharmacological inhibition of autophagy and NCOA4 knockdown attenuated iron accumulation and HYW-induced cytotoxicity. In cisplatin-resistant syngeneic tumors, HYW suppressed tumor growth with generally acceptable systemic tolerability, enhanced ferroptosis- and immunogenic stress-associated changes, reduced PD-L1 expression, and increased CD8 + T-cell infiltration. Moreover, HYW combined with anti-PD-1 treatment produced greater antitumor effects than either monotherapy. These findings suggest that HYW promotes ferroptosis through coordinated disruption of glutathione metabolism and NCOA4-associated ferritinophagy while enhancing antitumor immune responses in cisplatin-resistant ESCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI